Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study
This study has been completed.
Sponsor:
University of Zurich
Collaborator:
Sanofi
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01038011
First received: December 15, 2009
Last updated: February 2, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | August 2006 |
| Estimated Primary Completion Date: | No date given |